Correlation Between Bionoid Pharma and RIV Capital

Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and RIV Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and RIV Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bionoid Pharma and RIV Capital, you can compare the effects of market volatilities on Bionoid Pharma and RIV Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of RIV Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and RIV Capital.

Diversification Opportunities for Bionoid Pharma and RIV Capital

0.37

Correlation Coefficient

Bionoid Pharma  RIV Capital

Weak diversification

The 3 months correlation between Bionoid and RIV is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and RIV Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RIV Capital and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with RIV Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RIV Capital has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and RIV Capital go up and down completely randomly.

Pair Corralation between Bionoid Pharma and RIV Capital

Given the investment horizon of 90 days Bionoid Pharma is expected to generate 2.53 times more return on investment than RIV Capital. However, Bionoid Pharma is 2.53 times more volatile than RIV Capital. It trades about 0.12 of its potential returns per unit of risk. RIV Capital is currently generating about -0.12 per unit of risk. If you would invest  20.00  in Bionoid Pharma on September 20, 2024 and sell it today you would earn a total of  9.00  from holding Bionoid Pharma or generate 45.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Bionoid Pharma  vs.  RIV Capital

Bionoid Pharma

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

RIV Capital

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RIV Capital has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Bionoid Pharma and RIV Capital

The main advantage of trading using opposite Bionoid Pharma and RIV Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, RIV Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RIV Capital will offset losses from the drop in RIV Capital's long position.

The idea behind Bionoid Pharma and RIV Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.